Directory
>
Ken Prentice
Ken Prentice
Senior Vice President, Head of Process Development and Manufacturing | Shape Therapeutics Inc.
Seattle, Washington, United States
Ken Prentice
Summary
Ken Prentice is a seasoned leader in biotherapeutic drug development with over 20 years of experience. He has a proven track record of building innovative teams and advancing cutting-edge techniques in the biopharmaceutical space, particularly in CAR-T and rAAV gene therapies. Ken's expertise spans a wide array of technical disciplines including assay development, protein chemistry, and regulatory compliance. His leadership roles at Shape Therapeutics have allowed him to drive significant advancements in process and product development. He is known for his strategic planning capabilities and his ability to navigate complex regulatory landscapes. Ken is passionate about leveraging technology to enhance therapeutic outcomes and improve patient care. His academic background in Chemistry and Oceanography from the University of Washington complements his extensive industry experience. Ken's work is characterized by a blend of rigorous scientific inquiry and practical application, making him a valuable asset in the realm of biopharmaceuticals.
Ken Prentice
Work Experience
Senior Vice President, Head of Process Development and Manufacturing at
Shape Therapeutics Inc.
July 2024 - Present
Vice President, Head of Process and Product Development at
Shape Therapeutics Inc.
August 2021 - July 2024
Director, Head of Process and Product Development at
Shape Therapeutics Inc.
October 2020 - August 2021
Head of Process and Product Development at
Shape Therapeutics Inc.
March 2019 - August 2021
Senior Scientist at
Bristol Myers Squibb
March 2017 - March 2019
Scientist at
Bristol Myers Squibb
May 2015 - March 2017
Senior Associate Scientist, Analytical Sciences at
Amgen, Inc.
March 2013 - May 2015
Associate Scientist, Analytical and Formulation Sciences at
Amgen, Inc.
April 2008 - March 2013
Sr. Associate, Quality Control at
Amgen, Inc.
August 2002 - April 2008
Forensic Scientist 2 at
State of Washington
July 2000 - September 2002
Student Research Assistant at
University of Washington, LLC
October 1998 - June 2002
Ken Prentice
Education
January 1995 - January 2000
Frequently Asked Questions about Ken Prentice
What is Ken Prentice email address?
Ken Prentice's primary email address is ***@shapetx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Ken Prentice work for?
Ken Prentice is a Senior Vice President, Head of Process Development and Manufacturing at Shape Therapeutics Inc., a company specializing in Commercial physical research.
Where Ken Prentice graduated from?
Ken Prentice holds a degree in Chemistry And Oceanography from University of Washington.
How can I directly contact Ken Prentice?
To contact Ken Prentice directly, you can use the email address ***@shapetx.com. Complete contact information is available upon registration with Muraena.
Who is Ken Prentice?
Ken Prentice is a seasoned leader in biotherapeutic drug development with over 20 years of experience. He has a proven track record of building innovative teams and advancing cutting-edge techniques in the biopharmaceutical space, particularly in CAR-T and rAAV gene therapies. Ken's expertise spans a wide array of technical disciplines including assay development, protein chemistry, and regulatory compliance. His leadership roles at Shape Therapeutics have allowed him to drive significant advancements in process and product development. He is known for his strategic planning capabilities and his ability to navigate complex regulatory landscapes. Ken is passionate about leveraging technology to enhance therapeutic outcomes and improve patient care. His academic background in Chemistry and Oceanography from the University of Washington complements his extensive industry experience. Ken's work is characterized by a blend of rigorous scientific inquiry and practical application, making him a valuable asset in the realm of biopharmaceuticals.
Ken`s contact details
***@shapetx.com
************@junotherapeutics.com
Colleagues
Chief Business Officer
Senior Vice President, Head of Analytics and Informatics
General Counsel and Head of Operations
Interim Chief Executive Officer
Senior Vice President of Product
Vice President, People Operations
Co-Founder
Chief Technology Officer